Hashtagging Your Health: Instagram Influencers and Medical Promotions
It's no surprise that businesses have attempted to capitalize on that reach by partnering with “influencers,” but when pharmaceutical companies and health startups use influencer-advertising, do some details get lost in the posting?
March 06, 2019 at 03:12 PM
6 minute read
From reality TV star baby announcements to mysteriously popular eggs, Instagram's power to reach millions cannot be overstated. It's no surprise that businesses have attempted to capitalize on that reach by partnering with “influencers,” or users with thousands or millions of followers, to advertise their products. These partnerships are often lucrative for the influencers: Kim Kardashian, for example, reportedly charges more than $250,000 for an Instagram post. But when pharmaceutical companies and health startups use influencer-advertising, do some details get lost in the posting?
According to Vox, the answer is yes. And when it comes to regulating these ads, government agencies are still vague on setting boundaries.
The FDA mandates that ads for medical devices and pharmaceuticals must include possible risks of use as well as rewards, which is why television ads contain all those disclosures. But when it comes to social media, the FDA seems a little behind the times. According to Vox, the most recent FDA guidance for social media advertising was published in 2014 and doesn't even mention Instagram. The FTC's guidelines have been updated within the past two years. Both agencies recommend more disclosure in posts, but neither say how far into a post is best for that disclosure to be recognized.
Neither the FDA nor the FTC “attempt to survey all influencers or influencer post,” according to the FTC Advertising Practices Division. The agencies instead rely on consumers to flag non-compliant ads. Influencers are not likely to face the kinds of legal repercussions that a drug company would for leaving out information about a medication or a device. Consequences to the influencers would be at the discretion of the companies they've been contracted to represent.
In spite of hashtags like #sponsored and #partner, Instagram ads don't look like typical ads. That's part of their appeal, particularly to millennials. A survey by Yahoo says millennials will have close to $1.4 trillion in spending power by 2020, and because of their willingness to engage with and share content, that makes them a very desirable demographic.
British blogger Louise Roe has over 700,000 followers on Instagram and a paid partnership with Celgene, a biotech company that manufactures a psoriasis medication called Otezla. Roe has psoriasis herself, but Vox points out that apart from an acknowledgement of that paid partnership, there's no sign of her affliction on her posts. There are also no details about how Celgene won't necessarily work for someone the way it seems to work for Roe, but there are accompanying hashtags that mark such a post as an #Ad.
View this post on InstagramA post shared by Louise Roe (@louiseroe) on Oct 24, 2018 at 7:00am PDT
Travel blogger Lesley Murphy has a genetic mutation that increases her risk of certain cancers. She uses Instagram to talk to her 412,000 followers about health issues and even documented her preventive double mastectomy on the platform. She is also advertising ReSensation, a surgical technique that may help women who have had breast reconstruction retain some or all sensation in their breasts. Her posts are also hashtagged #partner to note that she's being paid for her advertisement, but she hasn't actually undergone the ReSensation technique herself. An Instagram post directs readers to her blog, where she not only discloses that she hasn't had the surgery but also that it would be incompatible with her implant reconstruction. Vox reports that the link to her blog does not take a reader directly to that information, making it difficult to find.
According to a report in the Journal of Medical Internet Research, one in three U.S. consumers consult social media for health-related matters. Instagram is projected to have more than 1.1 billion users in 2019.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
You Might Like
View All'Nuclear Option'?: Eli Lilly Taps Big Law Firms in Federal Drug Pricing Dispute
3 minute readBaltimore City Govt., After Winning Opioid Jury Trial, Preparing to Demand an Additional $11B for Abatement Costs
3 minute readDrugmaker Wins $70.5M After Fed Judge Says Generic Sales Were Blocked
4 minute readTrending Stories
- 1Gibson Dunn Sued By Crypto Client After Lateral Hire Causes Conflict of Interest
- 2Trump's Solicitor General Expected to 'Flip' Prelogar's Positions at Supreme Court
- 3Pharmacy Lawyers See Promise in NY Regulator's Curbs on PBM Industry
- 4Outgoing USPTO Director Kathi Vidal: ‘We All Want the Country to Be in a Better Place’
- 5Supreme Court Will Review Constitutionality Of FCC's Universal Service Fund
Who Got The Work
Michael G. Bongiorno, Andrew Scott Dulberg and Elizabeth E. Driscoll from Wilmer Cutler Pickering Hale and Dorr have stepped in to represent Symbotic Inc., an A.I.-enabled technology platform that focuses on increasing supply chain efficiency, and other defendants in a pending shareholder derivative lawsuit. The case, filed Oct. 2 in Massachusetts District Court by the Brown Law Firm on behalf of Stephen Austen, accuses certain officers and directors of misleading investors in regard to Symbotic's potential for margin growth by failing to disclose that the company was not equipped to timely deploy its systems or manage expenses through project delays. The case, assigned to U.S. District Judge Nathaniel M. Gorton, is 1:24-cv-12522, Austen v. Cohen et al.
Who Got The Work
Edmund Polubinski and Marie Killmond of Davis Polk & Wardwell have entered appearances for data platform software development company MongoDB and other defendants in a pending shareholder derivative lawsuit. The action, filed Oct. 7 in New York Southern District Court by the Brown Law Firm, accuses the company's directors and/or officers of falsely expressing confidence in the company’s restructuring of its sales incentive plan and downplaying the severity of decreases in its upfront commitments. The case is 1:24-cv-07594, Roy v. Ittycheria et al.
Who Got The Work
Amy O. Bruchs and Kurt F. Ellison of Michael Best & Friedrich have entered appearances for Epic Systems Corp. in a pending employment discrimination lawsuit. The suit was filed Sept. 7 in Wisconsin Western District Court by Levine Eisberner LLC and Siri & Glimstad on behalf of a project manager who claims that he was wrongfully terminated after applying for a religious exemption to the defendant's COVID-19 vaccine mandate. The case, assigned to U.S. Magistrate Judge Anita Marie Boor, is 3:24-cv-00630, Secker, Nathan v. Epic Systems Corporation.
Who Got The Work
David X. Sullivan, Thomas J. Finn and Gregory A. Hall from McCarter & English have entered appearances for Sunrun Installation Services in a pending civil rights lawsuit. The complaint was filed Sept. 4 in Connecticut District Court by attorney Robert M. Berke on behalf of former employee George Edward Steins, who was arrested and charged with employing an unregistered home improvement salesperson. The complaint alleges that had Sunrun informed the Connecticut Department of Consumer Protection that the plaintiff's employment had ended in 2017 and that he no longer held Sunrun's home improvement contractor license, he would not have been hit with charges, which were dismissed in May 2024. The case, assigned to U.S. District Judge Jeffrey A. Meyer, is 3:24-cv-01423, Steins v. Sunrun, Inc. et al.
Who Got The Work
Greenberg Traurig shareholder Joshua L. Raskin has entered an appearance for boohoo.com UK Ltd. in a pending patent infringement lawsuit. The suit, filed Sept. 3 in Texas Eastern District Court by Rozier Hardt McDonough on behalf of Alto Dynamics, asserts five patents related to an online shopping platform. The case, assigned to U.S. District Judge Rodney Gilstrap, is 2:24-cv-00719, Alto Dynamics, LLC v. boohoo.com UK Limited.
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250